MRI-guided laser ablation

LITT · MRI-guided laser interstitial thermal therapy

Treating a deep brain lesion without opening the skull. Laser interstitial thermal therapy (LITT) destroys pathological tissue through a 4 mm incision, with real-time thermal control by intraoperative MRI. A minimally invasive alternative to craniotomy in selected cases.

4 mm
incision and a single suture
1 vs 5 days
hospital stay compared to craniotomy1-8
+10,000
procedures performed in >210 centres worldwide

Laser energy controlled by MRI, millimetre by millimetre

Laser interstitial thermal therapy (LITT) is a minimally invasive procedure that destroys a brain lesion using a laser probe inserted stereotactically to the target. The procedure is carried out within an intraoperative MRI system that measures tissue temperature in real time and halts the application if it exits the safe range, protecting the surrounding healthy tissue.

Unlike craniotomy, it does not require opening the skull: a 4 mm incision, minimal hair shaving and a single suture are sufficient. The laser energy travels through an optical fibre to the tip of the catheter, where it heats the pathological tissue until controlled necrosis occurs.

LITT laser surgery guided by MRI
The indication for LITT is always validated in a multidisciplinary committee, contrasting its benefit/risk profile against conventional microsurgery, stereotactic radiosurgery and medical management.

When is LITT indicated?

The Visualase™ system is authorised in Europe for the ablation of intracranial soft tissues in cranial neurosurgery. Its use is reserved for selected cases, especially when the lesion is deep, surrounded by eloquent areas or the patient is not a candidate for craniotomy.

Brain tumours

Deep gliomas or in hard-to-access locations, recurrent lesions after surgery or radiosurgery, single brain metastases not resectable by open approach.

Radiation necrosis

Symptomatic radionecrosis after stereotactic radiosurgery, especially when the associated oedema is refractory to corticosteroids.

Drug-resistant epilepsy

Mesial temporal sclerosis, focal cortical dysplasias and other well-delimited epileptogenic lesions in patients who have failed two or more antiepileptic drugs.

Hypothalamic hamartomas

A common cause of gelastic seizures and early development. LITT allows disconnection of the hamartoma without the morbidity of a deep microsurgical approach.

What changes for the patient

The valid comparison is always against the alternative that would have been offered: in lesions where craniotomy is feasible, LITT does not automatically replace it. But when the case allows, the impact on the patient is very different.

Aspect LITT Open craniotomy
Incision~ 4 mmSeveral centimetres, requires cranial opening
Hospital stayTypical: 1-2 days1-8Typical: 4-5 days
Hair shavingMinimal, not cosmetically significantExtensive, depending on approach
Visible scarVirtually noneYes, in the cranial area
Infection riskReduced9,10Higher due to bone opening
Intraoperative controlReal-time temperature by MRIDirect visualisation under microscope

The comparison is indicative: each case requires individual assessment of the expected oncological, functional and vital benefit.

What LITT means in practice

LITT in practice: rapid recovery and minimal invasion

Short recovery

Most patients are discharged within 24 to 48 hours after the procedure1-8. Return to normal activity is typically faster than after an equivalent craniotomy.

Minimal aesthetic impact

Minimal shaving and an incision closed with one or two sutures, leaving no visible scar afterwards. An important consideration for many patients and their social reintegration.

Lower infection risk

The absence of bone opening reduces the risk of postoperative infectious complications compared to open approaches9,10.

Consistent oncological outcomes

In recurrent brain metastases after radiosurgery, published studies report resolution or reduction of symptoms in approximately 71 % of treated patients13.

Important. LITT does not replace craniotomy in all cases. The decision depends on the size, location and nature of the lesion, the patient's condition and therapeutic goals. Every indication is discussed in a multidisciplinary committee and contrasted with available alternatives. This page provides information but does not replace consultation with your medical team.

Step by step of a LITT or laser surgery procedure

  1. 1 · Case selection

    Review in a multidisciplinary committee (neurosurgery, neurology, oncology, radiology) to confirm that laser surgery offers the best benefit/risk ratio against microsurgery or radiosurgery.

  2. 2 · 3D planning

    Fusion of structural MRI, functional MRI (language, motor) and DTI tractography to calculate the safest trajectory, avoiding vessels and eloquent tracts.

  3. 3 · Minimal approach

    Punctual incision (3-5 mm), stereotactic introduction of the laser fibre to the lesion under neuronavigation.

  4. 4 · Ablation with thermal control

    Application of laser energy with real-time thermal monitoring via intraoperative MRI. The system automatically calculates and halts the application if the temperature exits the safe range.

  5. 5 · Closure and discharge

    Removal of the fibre and closure with a single suture. Immediate postoperative MRI to document the ablated area. Typical discharge within 24-48 h.

Reference neurosurgeon for LITT

MRI-guided laser interstitial ablation requires specific training in stereotactic neurosurgery and intraoperative image management. At Brain & Spine Barcelona, LITT is performed by Dr. Pedro Roldán.

Dr. Pedro Roldán Ramos

Dr. Pedro Roldán Ramos

Neurosurgeon · Stereotactic, functional and focal surgery

Indicates and performs MRI-guided laser ablation (LITT) at Brain & Spine Barcelona. Experience in stereotactic surgery, functional neurosurgery and minimally invasive approaches to the nervous system.

View full profile →
Scientific references
  1. Kang JY, Wu C, Tracy J, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia. 2016;57(2):325-334.
  2. Waseem H, Osborn KE, Schoenberg MR, et al. Laser ablation therapy: An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50. Epilepsy Behav. 2015;51:152-157.
  3. Jethwa PR, Barrese JC, Gowda A, Shetty A, Danish SF. Magnetic resonance thermometry-guided laser-induced thermal therapy for intracranial neoplasms: initial experience. Neurosurgery. 2012;71(1 Suppl Operative):133-145.
  4. Lewis EC, Weil AG, Duchowny M, Bhatia S, Ragheb J, Miller I. MR-guided laser interstitial thermal therapy for pediatric drug-resistant lesional epilepsy. Epilepsia. 2015;56(10):1590-1598.
  5. Patel P, Patel NV, Danish SF. Intracranial MR-guided laser-induced thermal therapy: single-center experience with the Visualase thermal therapy system. J Neurosurg. 2016;125(4):853-860.
  6. Wilfong AA, Curry DJ. Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis. Epilepsia. 2013;54 Suppl 9:109-114.
  7. Willie JT, Laxpati NG, Drane DL, et al. Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery. 2014;74(6):569-585.
  8. Petito GT, Wharen RE, Feyissa AM, Grewal SS, Lucas JA, Tatum WO. The impact of stereotactic laser ablation at a typical epilepsy center. Epilepsy Behav. 2018;78:37-44.
  9. Fabiano AJ, Alberico RA. Laser-interstitial thermal therapy for refractory cerebral edema from post-radiosurgery metastasis. World Neurosurg. 2014;81(3-4):652.e1-652.e6.
  10. Carpentier A, McNichols RJ, Stafford RJ, et al. Laser thermal therapy: real-time MRI-guided and computer-controlled procedures for metastatic brain tumors. Lasers Surg Med. 2011;43(10):943-950.
  11. Khu KJ, Doglietto F, Radovanovic I, et al. Patients' perceptions of awake and outpatient craniotomy for brain tumor: a qualitative study. J Neurosurg. 2010;112(5):1056-1060.
  12. Kim AH, Tatter S, Rao G, et al. Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor Ablation. Neurosurgery. 2020;87(3):E338-E346.
  13. Rao MS, Hargreaves EL, Khan AJ, et al. Magnetic resonance-guided laser ablation improves local control for postradiosurgery recurrence and/or radiation necrosis. Neurosurgery. 2014;74:658-667.
Patient reviews

What our patients say

5,0 Average rating on Doctoralia · testimonials anonymised with consent
High-grade glioma

"I arrived with a glioma I had been told was inoperable. Here they reviewed it at the tumour board and offered me a plan. The surgery was a success. Four years on, I am well."

M
M. · 52 years old
Operated on in 2022
Cervical disc herniation

"For years I had a cervical disc herniation, operated on by another team with no improvement. Minimally invasive surgery gave me back my mobility and took the pain away."

A
A. · 48 years old
Revision after a first surgery
International patient

"I travelled from outside Spain. The team reviewed my case before I came and gave me a clear plan. Caring people and impeccable technique."

L
L. · 39 years old
Remote second opinion
Medical team at Brain & Spine Barcelona: neurosurgeons, neurologists and nursing staff
A multidisciplinary team by your side. Neurosurgeons, neurologists and nursing staff working together on every case. Meet the whole team →
Request information

Is your case a candidate for LITT?

If you have a brain tumour, a well-delimited epileptogenic lesion or a recurrence after radiosurgery, we can assess your case in a multidisciplinary committee and advise whether MRI-guided laser ablation is a reasonable alternative for you.

Add specialty of interest (optional)

We reply within 24-48 working hours.